NanoString Technologies

Chief Business Officer

Dr. Murdter brings twenty years of experience in the life sciences and clinical diagnostics sectors.  She joined NanoString from Agilent Technologies where she held several senior management positions in business development, strategy and marketing including Sr. Director of Acquisitions, Alliances and Ventures and most recently Global Product Marketing Manager in the Life Sciences and Chemical Analysis division.  Prior to Agilent, Nalini was with Adeza Biomedical (later acquired by Cytyc/Hologic).  As the Director of Product and Business Development, she led the development and commercialization of clinical diagnostic products and closed key licensing and commercialization deals. She was a Senior Research Fellow at the California Institute of Technology.  Dr. Murdter received a Ph.D. in Biochemistry from the University of Maryland, and an M.B.A. from the Haas School of Business at UC Berkeley.